Heron Therapeutics
HRTX
HRTX
189 hedge funds and large institutions have $454M invested in Heron Therapeutics in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 67 increasing their positions, 39 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.65% more ownership
Funds ownership: 79.38% → 86.03% (+6.7%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
32% less call options, than puts
Call options by funds: $532K | Put options by funds: $781K
Holders
189
Holding in Top 10
4
Calls
$532K
Puts
$781K
Top Buyers
| 1 | +$16.4M | |
| 2 | +$9.94M | |
| 3 | +$4.43M | |
| 4 |
D.E. Shaw & Co
New York
|
+$4.09M |
| 5 |
BlackRock
New York
|
+$3.64M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$6.06M | |
| 3 | -$4.48M | |
| 4 |
Renaissance Technologies
New York
|
-$1.44M |
| 5 |
MAM
Monaco Asset Management
Monaco
|
-$1.05M |